Top compounds associated with response to GTF2A1L


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.02
mRNA TAE684 CTRPv2 pan-cancer AAC 0.078 0.02
mRNA NPC-26 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.093 0.03
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
mRNA SCH-529074 CTRPv2 pan-cancer AAC 0.076 0.04
mRNA decitabine CTRPv2 pan-cancer AAC -0.055 0.04
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.05
mRNA salermide CTRPv2 pan-cancer AAC -0.09 0.05
mRNA phloretin CTRPv2 pan-cancer AAC 0.067 0.05
Download CSV